Enochian Biosciences Inc (ENOB) SEC Filing 8-K Material Event for the period ending Thursday, July 5, 2018

Enochian Biosciences Inc

CIK: 1527728 Ticker: ENOB

View differences made from one to another to evaluate Enochian Biosciences Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Enochian Biosciences Inc.


Assess how Enochian Biosciences Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Enochian Biosciences Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Material Contracts, Statements, Certifications & more

Enochian Biosciences Inc provided additional information to their SEC Filing as exhibits

Ticker: ENOB
CIK: 1527728
Form Type: 8-K Corporate News
Accession Number: 0001731122-18-000025
Submitted to the SEC: Tue Jul 10 2018 6:02:48 AM EST
Accepted by the SEC: Tue Jul 10 2018
Period: Thursday, July 5, 2018
Industry: Pharmaceutical Preparations
  1. Accountant Change
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: